Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553221 · ClinicalTrials.gov registry record · NA
Talar Osteochondral Lesions With Pilon Fractures
A NA study, sponsored by University of Missouri-Columbia.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07553221: Clinical Trial NA study, sponsored by University of Missouri-Columbia.
NCT07553221 is a NA study that has not yet begun recruiting, run by University of Missouri-Columbia. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07553221, a NA study, has not yet begun recruiting, sponsored by University of Missouri-Columbia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Patients with pilon fractures have a high incidence of talar osteochondral lesions. In this study, patients will undergo ankle arthroscopy at the time of external fixation. The objective is to help determine the incidence of these lesions with pilon fractures and to see if these nano-arthroscopy results change the plan for definitive treatment.
Interventions
- PROCEDURE Diagnostic Ankle Nano-Arthroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-04 |
| Est. Completion | 2031-04 |
| Phase | NA |
What is known before NCT07553221 opens enrollment
NCT07553221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Ankle Nano-Arthroscopy is the first listed.
NCT07553221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07553221 about?
NCT07553221 is a clinical study titled "Talar Osteochondral Lesions With Pilon Fractures". Patients with pilon fractures have a high incidence of talar osteochondral lesions. In this study, patients will undergo ankle arthroscopy at the time of external fixation. The objective is to help determine the incidence of these lesions with pilon fractures and to see if these nano-arthroscopy res...
What is the current status of trial NCT07553221?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-04. Estimated completion is 2031-04.
What interventions are being tested in trial NCT07553221?
The interventions under investigation include: Diagnostic Ankle Nano-Arthroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT07553221?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07553221's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia